» Articles » PMID: 36404951

α-Ketoglutaramate-A Key Metabolite Contributing to Glutamine Addiction in Cancer Cells

Overview
Specialty General Medicine
Date 2022 Nov 21
PMID 36404951
Authors
Affiliations
Soon will be listed here.
Citing Articles

Metabolic Heterogeneity, Plasticity, and Adaptation to "Glutamine Addiction" in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase-ω-Amidase (Glutaminase II)] Pathway.

Cooper A, Dorai T, Pinto J, Denton T Biology (Basel). 2023; 12(8).

PMID: 37627015 PMC: 10452834. DOI: 10.3390/biology12081131.


Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies.

Nguyen T, Katt W, Cerione R Future Drug Discov. 2023; 4(4):FDD79.

PMID: 37009252 PMC: 10051075. DOI: 10.4155/fdd-2022-0011.

References
1.
Dorai T, Pinto J, Denton T, Krasnikov B, Cooper A . The metabolic importance of the glutaminase II pathway in normal and cancerous cells. Anal Biochem. 2020; 644:114083. DOI: 10.1016/j.ab.2020.114083. View

2.
Hoerner C, Chen V, Fan A . The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy. Kidney Cancer. 2019; 3(1):15-29. PMC: 6400133. DOI: 10.3233/KCA-180043. View

3.
Meister A, TICE S . Transamination from glutamine to alpha-keto acids. J Biol Chem. 1950; 187(1):173-87. View

4.
Delgir S, Bastami M, Ilkhani K, Safi A, Seif F, Alivand M . The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer. Mutat Res Rev Mutat Res. 2021; 787:108366. DOI: 10.1016/j.mrrev.2021.108366. View

5.
Hersh L . Rat liver omega-amidase. Purification and properties. Biochemistry. 1971; 10(15):2884-91. DOI: 10.1021/bi00791a014. View